Lyme Disease in Children

Carol A McCarthy; Jason A Helis; Brian E Daikh

doi:10.1016/j.idc.2022.03.002

Lyme Disease in Children

Infect Dis Clin North Am. 2022 Sep;36(3):593-603. doi: 10.1016/j.idc.2022.03.002.

Authors

Carol A McCarthy¹, Jason A Helis², Brian E Daikh³

Affiliations

¹ Department of Pediatrics, Division of Pediatric Infectious Disease, Barbara Bush Children's Hospital at Maine Medical Center, Portland, ME, USA; Tufts University School of Medicine, Boston, MA, USA; Maine Medical Partners Pediatric Specialty Care, 887 Congress Street, Suite 310, Portland, ME 04102, USA. Electronic address: Carol.McCarthy@mainehealth.org.
² Tufts University School of Medicine, Boston, MA, USA; Department of Pediatrics, Division of Pediatric Neurology, Barbara Bush Children's Hospital at Maine Medical Center, Portland, ME, USA; Maine Medical Partners Neurology, 92 Campus Drive Suite B, Scarborough, ME 04074, USA.
³ Tufts University School of Medicine, Boston, MA, USA; Department of Medicine, Maine Medical Center; Rheumatology Associates, 51 Sewall Street, Portland, ME, USA.

PMID: 36116837
DOI: 10.1016/j.idc.2022.03.002

Abstract

Lyme disease is now the most frequently reported vector-borne disease in the United States. The highest incidence is in children aged 5 to 9 years with a male predominance. The most common manifestation, erythema migrans, is sometimes not recognized, leading to risk of complications. Testing for Lyme disease should only be done if there is a consistent clinical syndrome with exposure in a Lyme-endemic area. Most forms of Lyme disease are successfully treated with short courses of oral therapy. Prevention and management of tick bites is important.

Keywords: Child; Intracranial hypertension; Lyme disease; Tick bites; Tick-borne diseases.

Publication types

Review

MeSH terms

Child
Erythema Chronicum Migrans* / complications
Erythema Chronicum Migrans* / epidemiology
Female
Humans
Incidence
Lyme Disease* / diagnosis
Lyme Disease* / drug therapy
Lyme Disease* / epidemiology
Male